Table 1.
Stilbenes | Proliferation | Migration | ||||
---|---|---|---|---|---|---|
HUVEC (%) | HMVEC (%) | HMEC-1 (%) | HUVEC (%) | HMVEC (%) | HMEC-1 (%) | |
RVT 0.5 µM | 73 ± 7* | 83 ± 4* | 92 ± 2* | 83 ± 2* | 91 ± 2* | 84 ± 4* |
RVT 10 µM | 76 ± 3* | 92 ± 2* | 84 ± 3* | 74 ± 5* | 87 ± 3* | 66 ± 5* |
3,3′,4,4′-THS 0.5 µM | 137 ± 13* | 103 ± 7 | 95 ± 6 | 105 ± 7 | 106 ± 6 | 105 ± 8 |
3,3′,4,4′-THS 10 µM | 133 ± 15* | 112 ± 11 | 112 ± 14 | 112 ± 8 | 116 ± 10 | 114 ± 14 |
3,3′,4,4′,5,5′-HHS 0.5 µM | 128 ± 6* | 106 ± 7 | 101 ± 6 | 101 ± 2 | 106 ± 9 | 114 ± 11 |
3,3′,4,4′,5,5′-HHS 10 µM | 142 ± 6* | 102 ± 5 | 92 ± 9 | 109 ± 5 | 98 ± 4 | 102 ± 9 |
The results are expressed as a percentage of the control (untreated) cells. The asterisks indicate a significant difference compared to the control group. The results derive from 8 to 12 experiments performed for each type of endothelial cells in triplicates